PharmaCyte Biotech Inc PMCB:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/20/22 EDT
2.22quote price arrow down-0.05 (-2.20%)
Volume
40,651
52 week range
1.79 - 21.45
Loading...
  • Open2.30
  • Day High2.30
  • Day Low2.18
  • Prev Close2.27
  • 52 Week High21.45
  • 52 Week High Date06/28/21
  • 52 Week Low1.79
  • 52 Week Low Date02/24/22

Key Stats

  • Market Cap46.00M
  • Shares Out20.72M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta-0.02
  • YTD % Change-11.2

KEY STATS

  • Open2.30
  • Day High2.30
  • Day Low2.18
  • Prev Close2.27
  • 52 Week High21.45
  • 52 Week High Date06/28/21
  • 52 Week Low1.79
  • 52 Week Low Date02/24/22
  • Market Cap46.00M
  • Shares Out20.72M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta-0.02
  • YTD % Change-11.2

RATIOS/PROFITABILITY

  • EPS (TTM)-1.35
  • P/E (TTM)-1.64
  • Fwd P/E (NTM)-55.50
  • EBITDA (TTM)-3.919M
  • ROE (TTM)-7.63%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On PharmaCyte Biotech Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
PharmaCyte Biotech, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for cancer and diabetes based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Cell-in-a-Box technology is used as a platform upon which therapies for several types of cancer, including locally advanced, inoperable, non-metastatic pancreatic cancer (LAPC). The Company's lead product candidate, CypCaps is in Phase II of...
Kenneth Waggoner J.D.
Chairman of the Board, President, Chief Executive Officer, General Counsel
Carlos Trujillo CPA
Chief Financial Officer, Director
Address
23046 Avenida de La Carlota Ste 600
Laguna Hills, CA
92653-1537
United States